Cel Sci (CVM) Shares Outstanding (Entity) (2010 - 2026)
Cel Sci (CVM) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 133.73 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | 252.88 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 218.28 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 575.47 Mn |
| 10 | Cel Sci | 2.18 Mn | -4.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 749,786.00 |
| Jun 30, 2025 | 588,121.00 |
| Mar 31, 2025 | 598,960.00 |
| Dec 31, 2024 | 632,651.00 |
| Sep 30, 2024 | 583,202.00 |
| Jun 30, 2024 | 1.81 Mn |
| Mar 31, 2024 | 1.80 Mn |
| Dec 31, 2023 | 1.67 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.49 Mn |
| Mar 31, 2023 | 1.46 Mn |
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 1.45 Mn |
| Jun 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 1.44 Mn |
| Dec 31, 2021 | 1.44 Mn |
| Sep 30, 2021 | 1.44 Mn |
| Jun 30, 2021 | 1.43 Mn |